Intracranial Stents Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global intracranial stents market was valued at USD 222 million in 2025 and is projected to grow from USD 234 million in 2026 to reach USD 284 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period. Intracranial stents are highly specialized tubular medical devices engineered for precise placement within the delicate blood vessels of the intracranial cavity to treat complex vascular abnormalities. Unlike conventional stents used in other parts of the body, these devices are meticulously designed for neurological applications, primarily to manage life-threatening cerebrovascular conditions such as ischemic and hemorrhagic strokes. By reinforcing weakened arterial walls and re-establishing proper blood flow, these stents play a critical role in preventing aneurysm rupture and reducing the recurrence of strokes, making them indispensable in modern neuro-interventional medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download sample/1715/intracranial-stents-market

Pharmaceutical E-commerce Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pharmaceutical e-commerce market is valued at USD 75.2 billion in 2026 and is projected to reach USD 185.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period. Pharmaceutical e-commerce refers to the online sale and distribution of prescription medicines, over-the-counter (OTC) products, health supplements, and wellness items through digital platforms. This transformative channel facilitates transactions between pharmacies, distributors, and consumers via websites and mobile applications, encompassing both business-to-consumer (B2C) and business-to-business (B2B) models. The integration of telemedicine services for electronic prescription fulfillment is revolutionizing how patients access chronic and acute medications, offering unprecedented convenience and accessibility. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10357/pharmaceutical-e-commerce-market

Pre-Pregnancy Genetic Testing Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pre-pregnancy genetic testing market is valued at USD 1.83 billion in 2026 and is projected to reach USD 3.87 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period. Pre-pregnancy genetic testing, clinically known as carrier screening, is a vital diagnostic tool used to identify individuals or couples who carry gene mutations that could lead to serious genetic disorders in their offspring, such as cystic fibrosis, spinal muscular atrophy (SMA), and fragile X syndrome. These tests, typically performed via blood or saliva samples, provide essential information for informed family planning and reproductive decision-making. The increasing integration of advanced genomic technologies and rising awareness about hereditary conditions are fundamentally transforming preconception care worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9121/pre-pregnancy-genetic-testing-market

Key players operating in the global Pressure-less Silver Sintering Paste Market with company profiles and strategic developments Global Pressure-less Silver Sintering Paste Market continues to gain significant momentum, valued at USD 93 million in 2026 and projected to expand at a CAGR of 4.60% to reach USD 127.41 million by 2034. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/287084/global-pressureless-silver-sintering-paste-forecast-market-2025-2032-218

Who Are the Key Players Driving Innovation in the Waxy Corn Starch Market ? Global Waxy Corn Starch Market was valued at USD 253 million in 2026 and is projected to reach USD 320 million by 2034, exhibiting a steady CAGR of 3.8% during the forecast period. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/299345/waxy-corn-starch-market

Top 10 Companies Shaping the Global Parathyroid Disorders Market (2026–2034) According to a newly published market research report by 24LifeSciences, global parathyroid disorders market is valued at USD 2.1 billion in 2026 and is projected to reach USD 3.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Parathyroid disorders are medical conditions resulting from the dysfunction of the parathyroid glands, four small glands located in the neck that regulate the body's calcium levels. These disorders lead to abnormal calcium levels in the blood, which can cause significant health issues such as brittle bones (osteoporosis), kidney stones, chronic fatigue, and muscle weakness. The primary disorders include hyperparathyroidism (overactive glands), hypoparathyroidism (underactive glands), and the rare parathyroid cancer. Market growth is primarily driven by an aging global population more susceptible to these conditions and the rising prevalence of chronic kidney disease (CKD), a major cause of secondary hyperparathyroidism. Furthermore, advancements in diagnostic techniques, such as more sensitive parathyroid hormone (PTH) assays, are facilitating earlier and more accurate detection. Key players like Amgen, with its calcimimetic drug Cinacalcet, and Abbott Laboratories, a leader in diagnostic solutions, are actively shaping the treatment landscape through innovation and strategic initiatives, contributing to market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9574/parathyroid-disorders-market

Global RA Drugs Market Size, Share & Forecast to 2032 | Key Players According to a newly published market research report by 24LifeSciences, global rheumatoid arthritis (RA) drugs market was valued at USD 60.2 billion in 2026 and is projected to reach USD 78.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period. Rheumatoid Arthritis (RA) drugs represent the cornerstone of treatment for a chronic autoimmune disorder characterized by persistent joint inflammation, pain, and progressive disability. The therapeutic landscape has evolved significantly beyond symptomatic relief with NSAIDs and corticosteroids to include advanced Disease-Modifying Antirheumatic Drugs (DMARDs), biologic agents targeting specific immune pathways, and innovative Janus kinase (JAK) inhibitors. These treatments aim to achieve disease remission, prevent structural joint damage, and improve long-term patient outcomes, making them essential in modern rheumatology practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9176/rheumatoid-arthritis-ra-drugs-market

Global RA Drugs Market Size, Share & Forecast to 2032 | Key Players According to a newly published market research report by 24LifeSciences, global rheumatoid arthritis (RA) drugs market was valued at USD 60.2 billion in 2026 and is projected to reach USD 78.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period. Rheumatoid Arthritis (RA) drugs represent the cornerstone of treatment for a chronic autoimmune disorder characterized by persistent joint inflammation, pain, and progressive disability. The therapeutic landscape has evolved significantly beyond symptomatic relief with NSAIDs and corticosteroids to include advanced Disease-Modifying Antirheumatic Drugs (DMARDs), biologic agents targeting specific immune pathways, and innovative Janus kinase (JAK) inhibitors. These treatments aim to achieve disease remission, prevent structural joint damage, and improve long-term patient outcomes, making them essential in modern rheumatology practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9176/rheumatoid-arthritis-ra-drugs-market

Ultrasonic Skin Tightening Instruments Market Outlook 2026: Trends & Key Players According to a newly published market research report by 24LifeSciences, global ultrasonic skin tightening instruments market was valued at USD 623.4 million in 2026 and is projected to reach USD 1.12 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period. Ultrasonic skin tightening instruments represent an advanced category of non-invasive aesthetic devices that utilize focused ultrasound energy to target deep dermal layers, stimulating collagen production and resulting in firmer, more youthful-looking skin. These devices deliver precise thermal energy to specific tissue depths, causing controlled coagulation that triggers the body's natural healing response. This technology has revolutionized the aesthetics industry by offering a viable alternative to surgical facelifts and invasive procedures, providing noticeable results with minimal downtime and reduced risk profile. The procedure's efficacy in addressing skin laxity, fine lines, and contour irregularities continues to establish its importance in dermatology and cosmetic medicine practices worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10273/ultrasonic-skin-tightening-instruments-market

Top 10 Key Players Transforming the Global Hydroxyzine Imine Market (2026–2034) According to a newly published market research report by 24LifeSciences, global Hydroxyzine Imine market was valued at USD 797 million in 2026 and is projected to reach USD 1172 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Hydroxyzine Imine, a critical pharmaceutical intermediate, is the precursor in synthesizing hydroxyzine hydrochloride and hydroxyzine pamoate, which are first-generation antihistamines and central nervous system depressants. These final active pharmaceutical ingredients (APIs) are essential for medications primarily indicated to manage anxiety and provide symptomatic relief from pruritus (itching) due to allergic conditions like chronic urticaria and atopic dermatitis. Its established role in allergy and anxiety management continues to underpin its significance in both dermatology and psychiatric therapeutic areas. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9259/hydroxyzine-imine-market

Top 10 Key Players Transforming the Quaternary Ammonium Salts Disinfectant Market According to a newly published market research report by 24LifeSciences, global quaternary ammonium salts disinfectant market value is at USD 1.5 billion in 2026 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period. Quaternary ammonium compounds, commonly known as quats, are a class of positively charged antimicrobial agents widely recognized for their effective disinfection properties. They function by disrupting the cell membranes of microorganisms, leading to the inactivation of a broad spectrum of pathogens, including bacteria, enveloped viruses, and fungi. Their efficacy, combined with relatively low toxicity and stability, makes them a fundamental component in infection control protocols across healthcare, food processing, and institutional cleaning sectors. The lasting emphasis on hygiene, accelerated by the COVID-19 pandemic, continues to drive their adoption and innovation. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10348/quaternary-ammonium-salts-disinfectant-market

Key players operating in the global Rosin Modified Phenolic Resin Coatings Market with company profiles and strategic developments The global Rosin Modified Phenolic Resin Coatings Market is poised for steady growth, projected to achieve a valuation of US$ 312.5 million by 2030 at a CAGR of 3.8% from 2024 onward. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/272726/global-rosin-modified-phenolic-resin-coatings-market-2024-2030-134